Literature DB >> 24843141

Mechanisms controlling the smooth muscle cell death in progeria via down-regulation of poly(ADP-ribose) polymerase 1.

Haoyue Zhang1, Zheng-Mei Xiong1, Kan Cao2.   

Abstract

Hutchinson-Gilford progeria syndrome (HGPS) is a severe human premature aging disorder caused by a lamin A mutant named progerin. Death occurs at a mean age of 13 y from cardiovascular problems. Previous studies revealed loss of vascular smooth muscle cells (SMCs) in the media of large arteries in a patient with HGPS and two mouse models, suggesting a causal connection between the SMC loss and cardiovascular malfunction. However, the mechanisms of how progerin leads to massive SMC loss are unknown. In this study, using SMCs differentiated from HGPS induced pluripotent stem cells, we show that HGPS SMCs exhibit a profound proliferative defect, which is primarily caused by caspase-independent cell death. Importantly, progerin accumulation stimulates a powerful suppression of PARP1 and consequently triggers an activation of the error-prone nonhomologous end joining response. As a result, most HGPS SMCs exhibit prolonged mitosis and die of mitotic catastrophe. This study demonstrates a critical role of PARP1 in mediating SMC loss in patients with HGPS and elucidates a molecular pathway underlying the progressive SMC loss in progeria.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24843141      PMCID: PMC4050581          DOI: 10.1073/pnas.1320843111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  53 in total

Review 1.  Death through a tragedy: mitotic catastrophe.

Authors:  H Vakifahmetoglu; M Olsson; B Zhivotovsky
Journal:  Cell Death Differ       Date:  2008-04-11       Impact factor: 15.828

Review 2.  Mitotic catastrophe: a mechanism for avoiding genomic instability.

Authors:  Ilio Vitale; Lorenzo Galluzzi; Maria Castedo; Guido Kroemer
Journal:  Nat Rev Mol Cell Biol       Date:  2011-04-29       Impact factor: 94.444

3.  Mutant nuclear lamin A leads to progressive alterations of epigenetic control in premature aging.

Authors:  Dale K Shumaker; Thomas Dechat; Alexander Kohlmaier; Stephen A Adam; Matthew R Bozovsky; Michael R Erdos; Maria Eriksson; Anne E Goldman; Satya Khuon; Francis S Collins; Thomas Jenuwein; Robert D Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-31       Impact factor: 11.205

4.  Topoisomerase I poisoning results in PARP-mediated replication fork reversal.

Authors:  Arnab Ray Chaudhuri; Yoshitami Hashimoto; Raquel Herrador; Kai J Neelsen; Daniele Fachinetti; Rodrigo Bermejo; Andrea Cocito; Vincenzo Costanzo; Massimo Lopes
Journal:  Nat Struct Mol Biol       Date:  2012-03-04       Impact factor: 15.369

5.  Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders.

Authors:  Darren J Baker; Tobias Wijshake; Tamar Tchkonia; Nathan K LeBrasseur; Bennett G Childs; Bart van de Sluis; James L Kirkland; Jan M van Deursen
Journal:  Nature       Date:  2011-11-02       Impact factor: 49.962

6.  Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome.

Authors:  Maria Eriksson; W Ted Brown; Leslie B Gordon; Michael W Glynn; Joel Singer; Laura Scott; Michael R Erdos; Christiane M Robbins; Tracy Y Moses; Peter Berglund; Amalia Dutra; Evgenia Pak; Sandra Durkin; Antonei B Csoka; Michael Boehnke; Thomas W Glover; Francis S Collins
Journal:  Nature       Date:  2003-04-25       Impact factor: 49.962

7.  PARP1-dependent kinetics of recruitment of MRE11 and NBS1 proteins to multiple DNA damage sites.

Authors:  Jean-François Haince; Darin McDonald; Amélie Rodrigue; Ugo Déry; Jean-Yves Masson; Michael J Hendzel; Guy G Poirier
Journal:  J Biol Chem       Date:  2007-11-19       Impact factor: 5.157

8.  Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome.

Authors:  Robert D Goldman; Dale K Shumaker; Michael R Erdos; Maria Eriksson; Anne E Goldman; Leslie B Gordon; Yosef Gruenbaum; Satya Khuon; Melissa Mendez; Renée Varga; Francis S Collins
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-07       Impact factor: 11.205

9.  Phenotype and course of Hutchinson-Gilford progeria syndrome.

Authors:  Melissa A Merideth; Leslie B Gordon; Sarah Clauss; Vandana Sachdev; Ann C M Smith; Monique B Perry; Carmen C Brewer; Christopher Zalewski; H Jeffrey Kim; Beth Solomon; Brian P Brooks; Lynn H Gerber; Maria L Turner; Demetrio L Domingo; Thomas C Hart; Jennifer Graf; James C Reynolds; Andrea Gropman; Jack A Yanovski; Marie Gerhard-Herman; Francis S Collins; Elizabeth G Nabel; Richard O Cannon; William A Gahl; Wendy J Introne
Journal:  N Engl J Med       Date:  2008-02-07       Impact factor: 91.245

10.  The mutant form of lamin A that causes Hutchinson-Gilford progeria is a biomarker of cellular aging in human skin.

Authors:  Dayle McClintock; Desiree Ratner; Meepa Lokuge; David M Owens; Leslie B Gordon; Francis S Collins; Karima Djabali
Journal:  PLoS One       Date:  2007-12-05       Impact factor: 3.240

View more
  38 in total

Review 1.  NAD and the aging process: Role in life, death and everything in between.

Authors:  Claudia C S Chini; Mariana G Tarragó; Eduardo N Chini
Journal:  Mol Cell Endocrinol       Date:  2016-11-05       Impact factor: 4.102

2.  CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism.

Authors:  Juliana Camacho-Pereira; Mariana G Tarragó; Claudia C S Chini; Veronica Nin; Carlos Escande; Gina M Warner; Amrutesh S Puranik; Renee A Schoon; Joel M Reid; Antonio Galina; Eduardo N Chini
Journal:  Cell Metab       Date:  2016-06-14       Impact factor: 27.287

Review 3.  DNA repair defects and genome instability in Hutchinson-Gilford Progeria Syndrome.

Authors:  Susana Gonzalo; Ray Kreienkamp
Journal:  Curr Opin Cell Biol       Date:  2015-06-12       Impact factor: 8.382

Review 4.  Shared molecular and cellular mechanisms of premature ageing and ageing-associated diseases.

Authors:  Nard Kubben; Tom Misteli
Journal:  Nat Rev Mol Cell Biol       Date:  2017-08-09       Impact factor: 94.444

5.  Progerin-expressing endothelial cells are unable to adapt to shear stress.

Authors:  Brooke E Danielsson; Hannah C Peters; Kranthi Bathula; Lindsay M Spear; Natalie A Noll; Kris N Dahl; Daniel E Conway
Journal:  Biophys J       Date:  2022-01-06       Impact factor: 4.033

6.  Interruption of progerin-lamin A/C binding ameliorates Hutchinson-Gilford progeria syndrome phenotype.

Authors:  Su-Jin Lee; Youn-Sang Jung; Min-Ho Yoon; So-Mi Kang; Ah-Young Oh; Jee-Hyun Lee; So-Young Jun; Tae-Gyun Woo; Ho-Young Chun; Sang Kyum Kim; Kyu Jin Chung; Ho-Young Lee; Kyeong Lee; Guanghai Jin; Min-Kyun Na; Nam Chul Ha; Clea Bárcena; José M P Freije; Carlos López-Otín; Gyu Yong Song; Bum-Joon Park
Journal:  J Clin Invest       Date:  2016-09-12       Impact factor: 14.808

7.  Diminished Canonical β-Catenin Signaling During Osteoblast Differentiation Contributes to Osteopenia in Progeria.

Authors:  Ji Young Choi; Jim K Lai; Zheng-Mei Xiong; Margaret Ren; Megan C Moorer; Joseph P Stains; Kan Cao
Journal:  J Bone Miner Res       Date:  2018-08-01       Impact factor: 6.741

Review 8.  Kynurenine pathway, NAD+ synthesis, and mitochondrial function: Targeting tryptophan metabolism to promote longevity and healthspan.

Authors:  Raul Castro-Portuguez; George L Sutphin
Journal:  Exp Gerontol       Date:  2020-01-16       Impact factor: 4.032

9.  Alteration of genetic recombination and double-strand break repair in human cells by progerin expression.

Authors:  Celina J Komari; Anne O Guttman; Shelby R Carr; Taylor L Trachtenberg; Elise A Orloff; Ashley V Haas; Andrew R Patrick; Sona Chowdhary; Barbara C Waldman; Alan S Waldman
Journal:  DNA Repair (Amst)       Date:  2020-09-28

Review 10.  Molecular and Cellular Mechanisms Driving Cardiovascular Disease in Hutchinson-Gilford Progeria Syndrome: Lessons Learned from Animal Models.

Authors:  Ignacio Benedicto; Beatriz Dorado; Vicente Andrés
Journal:  Cells       Date:  2021-05-11       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.